Literature DB >> 6481579

The "critical" neonate with diaphragmatic hernia: a 21-year perspective.

M Reynolds, S R Luck, R Lappen.   

Abstract

We have seen a modest improvement in the survival of a homogeneous group of critically ill newborns with congenital diaphragmatic hernia since 1979. Twenty-seven "critical" infants have been treated who developed respiratory distress shortly after birth, required urgent resuscitation, and could not be stabilized before operation. Two died with other anomalies that appeared incompatible with prolonged survival. Ten of the 27 lived. This survival contrasts with that of only two of 17 similarly affected babies treated from 1962 to 1978. In addition, there has been no operative mortality outside of this "critical" group since 1979; whereas six noncritical babies died between 1967 to 1978. Our current therapeutic plan includes the early establishment of a respiratory alkalosis and vasodilator therapy before or during transport. Postoperatively we have attempted to maintain the baby's arterial pH greater than 7.5, Pco2 less than 25 to 30 and the PO2 approximately 150 torr. The most effective ventilatory parameters have been a rate of 130, PEEP of 5 and an inspiratory:expiratory ratio of 1:1. Peak airway pressures are kept as low as possible. Pharmacologic and ventilator therapy are weaned slowly, and intensive support has been required for at least 48 hours in each baby. Retained secretions and atelectasis of the hypoplastic lung persisted for two to several weeks postoperatively. Two babies that are one year or older still appear to have severely hypoplastic lungs on chest x-ray. M-mode echocardiography has been used to measure ventricular ejection periods. The right ventricular systolic time interval correlates with the degree of pulmonary hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6481579     DOI: 10.1016/s0022-3468(84)80254-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Preoperative stabilisation in congenital diaphragmatic hernia.

Authors:  L K Shanbhogue; P K Tam; G Ninan; D A Lloyd
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Current management of congenital diaphragmatic hernia.

Authors:  S Khwaja; C Grant
Journal:  Indian J Pediatr       Date:  1986 Jan-Feb       Impact factor: 1.967

3.  Preoperative stabilisation in congenital diaphragmatic hernia.

Authors:  P H Cartlidge; N P Mann; L Kapila
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

4.  Is prognostication in congenital diaphragmatic hernia possible without sophisticated investigations?

Authors:  D Sharma; A Saxena; V K Raina
Journal:  Indian J Pediatr       Date:  1999 Jul-Aug       Impact factor: 1.967

5.  Survival Disparities Associated with Congenital Diaphragmatic Hernia.

Authors:  Cynthia F Hinton; Csaba Siffel; Adolfo Correa; Stuart K Shapira
Journal:  Birth Defects Res       Date:  2017-04-10       Impact factor: 2.344

6.  Recent experience with diaphragmatic hernia and ECMO.

Authors:  C G Howell; R M Hatley; R F Boedy; D M Rogers; W P Kanto; R A Parrish
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

7.  Delayed surgery for congenital diaphragmatic hernia: neurodevelopmental outcome in later childhood.

Authors:  M Davenport; E Rivlin; S W D'Souza; A Bianchi
Journal:  Arch Dis Child       Date:  1992-11       Impact factor: 3.791

Review 8.  Reversal of mortality for congenital diaphragmatic hernia with ECMO.

Authors:  K Heiss; P Manning; K T Oldham; A G Coran; T Z Polley; J R Wesley; R H Bartlett
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

9.  Survival of outborns with congenital diaphragmatic hernia: the role of protective ventilation, early presentation and transport distance: a retrospective cohort study.

Authors:  Katarina Bojanić; Ena Pritišanac; Tomislav Luetić; Jurica Vuković; Juraj Sprung; Toby N Weingarten; William A Carey; Darrell R Schroeder; Ruža Grizelj
Journal:  BMC Pediatr       Date:  2015-10-12       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.